$13.89
-0.69-4.73%
At Close: -
$13.89
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Mineralys Therapeutics
MLYSNASDAQ
Mineralys Therapeutics (MLYS) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMineralys Therapeutics (NASDAQ:MLYS) Stock Quotes, Forecast and News Summary
Mineralys Therapeutics Stock (NASDAQ: MLYS) stock price, news, charts, stock research, profile.
| Open | $14.35 |
| Close | $13.89 |
| Volume / Avg. | 204.65K / 196.14K |
| Day Range | 13.84 - 14.67 |
| 52 Wk Range | 5.85 - 16.91 |
| Market Cap | $689.62M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 60 |
| Short Interest | 3.38% |
| Days to Cover | 2.57 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Mineralys Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medic...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mineralys Therapeutics (MLYS) stock?
You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.
Who are Mineralys Therapeutics (MLYS) competitors?
Other companies in Mineralys Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and Sage Therapeutics (NASDAQ:SAGE).
What is the target price for Mineralys Therapeutics (MLYS) stock?
There is no analysis for Mineralys Therapeutics.
What is the forecast for Mineralys Therapeutics (MLYS) stock?
Mineralys Therapeutics has a consensus price target of $34.29.
Current stock price for Mineralys Therapeutics (MLYS)?
The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $13.89 last updated Today at July 17, 2024 at 4:00 PM EDT.
Does Mineralys Therapeutics (MLYS) pay a dividend?
There are no upcoming dividends for Mineralys Therapeutics.
When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?
Mineralys Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is Mineralys Therapeutics (MLYS) going to split?
There is no upcoming split for Mineralys Therapeutics.
What sector and industry does Mineralys Therapeutics (MLYS) operate in?
Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.